COMMUNIQUÉS West-GlobeNewswire

Tyme Technologies Announces Pricing of its Offering of 9 Million Shares of Common Stock

02/03/2018 - 03:46

NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ) (the “Company”) announced today that it has priced its underwritten public offering of 9 million shares of its common stock, par value [...]

Reata Announces Top-Line Data from the Dose-Escalation Cohorts of the Phase 2 Motor Study of Omaveloxolone in Patients With Mitochondrial Myopathies

01/03/2018 - 23:14

IRVING, Texas, March 01, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA ) (Reata or Company), a clinical-stage biopharmaceutical company, today announced top-line data from the dose-escalation [...]

Dentsply Sirona Reports Preliminary Fourth Quarter and Full Year 2017 Results

01/03/2018 - 23:01

Reported Q4 revenues of $1,091.0 million, up 9.5% compared to prior year; constant currency growth 1 of 5.3% A Q4 2017 GAAP EPS loss of $2.95 including incremental non-cash charges of $847.9 million Q4 2017 non-GAAP [...]

3D Signatures Reports Quarter Ended December 31, 2017 Financial Results

01/03/2018 - 23:00

TORONTO, March 01, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS" ), a personalized medicine company with a proprietary software platform based on the three- [...]

Jounce Therapeutics to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on Thursday, March 8, 2018

01/03/2018 - 22:52

CAMBRIDGE, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]

Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

01/03/2018 - 22:45

BERKELEY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today announced that on March 1, 2018 the Compensation Committee of Dynavax’s Board of Directors approved the grant [...]

MyoKardia to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 8, 2018

01/03/2018 - 22:30

SOUTH SAN FRANCISCO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]

Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2017 Financial Results

01/03/2018 - 22:30

BOSTON, March 01, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq: ZFGN ), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]

Beleave Provides Update on Manitoba Retail Licensing Agreement

01/03/2018 - 22:30

TORONTO, March 01, 2018 (GLOBE NEWSWIRE) -- Beleave Inc. (" Beleave " or the " Company ") (CSE:BE); (OTCQX:BLEVF) would like to provide an update with regard to recent retail licensing grants in the province of Manitoba [...]

Teladoc Announces Expanded Collaboration with Microsoft

01/03/2018 - 22:25

PURCHASE, NY, March 01, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), the world’s largest and most trusted provider of virtual care delivery services, announced today its expanded collaboration with Microsoft. [...]

Ovid Therapeutics Announces Multiple Poster Presentations of OV101 and TAK-935/OV935 at the American Academy of Neurology 70th Annual Meeting

01/03/2018 - 22:23

NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, [...]

Ritter Pharmaceuticals, Inc.’s Board Approves 1-for-10 Reverse Stock Split

01/03/2018 - 22:20

Los Angeles, California, March 01, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a leading developer of novel therapeutic products that modulate the [...]

TESARO Announces Participation at Two Investor Conferences

01/03/2018 - 22:15

WALTHAM, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences [...]

Humanigen CEO to Present at Inaugural LD Micro Virtual Conference

01/03/2018 - 22:15

BRISBANE, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and [...]

Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

01/03/2018 - 22:10

BURLINGAME, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]

Genesis HealthCare Regains Compliance With NYSE Continued Listing Standard

01/03/2018 - 22:05

KENNETT SQUARE, Pa., March 01, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE: GEN ) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it received written [...]

CytomX to Present at Upcoming Investor Conferences

01/03/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX ), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today [...]

ICU Medical, Inc. Announces Fourth Quarter and Fiscal Year 2017 Results

01/03/2018 - 22:05

SAN CLEMENTE, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI ), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

01/03/2018 - 22:05

BOSTON, March 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]